Annual FCF
-$62.30 M
+$4.45 M+6.66%
December 31, 2024
Summary
- As of March 9, 2025, BDTX annual free cash flow is -$62.30 million, with the most recent change of +$4.45 million (+6.66%) on December 31, 2024.
- During the last 3 years, BDTX annual FCF has risen by +$40.55 million (+39.43%).
- BDTX annual FCF is now -2466.02% below its all-time high of -$2.43 million, reached on December 31, 2017.
Performance
BDTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$15.05 M
-$3.73 M-32.96%
December 1, 2024
Summary
- As of March 9, 2025, BDTX quarterly free cash flow is -$15.05 million, with the most recent change of -$3.73 million (-32.96%) on December 1, 2024.
- Over the past year, BDTX quarterly FCF has dropped by -$1.10 million (-7.87%).
- BDTX quarterly FCF is now -201.22% below its all-time high of -$5.00 million, reached on June 30, 2019.
Performance
BDTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$62.30 M
-$1.10 M-1.80%
December 1, 2024
Summary
- As of March 9, 2025, BDTX TTM free cash flow is -$62.30 million, with the most recent change of -$1.10 million (-1.80%) on December 1, 2024.
- Over the past year, BDTX TTM FCF has increased by +$4.45 million (+6.66%).
- BDTX TTM FCF is now -804.52% below its all-time high of -$6.89 million, reached on March 31, 2019.
Performance
BDTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BDTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | -7.9% | +6.7% |
| 3 y3 years | +39.4% | +38.3% | +39.4% |
| 5 y5 years | -152.3% | -101.1% | -152.3% |
BDTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.4% | -33.0% | +47.4% | -1.8% | +41.8% |
| 5 y | 5-year | -152.3% | +39.4% | -101.1% | +47.4% | -152.3% | +41.8% |
| alltime | all time | -2466.0% | +39.4% | -201.2% | +47.4% | -804.5% | +41.8% |
Black Diamond Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$62.30 M(-6.7%) | - | - |
| Dec 2024 | - | -$15.05 M(+33.0%) | -$62.30 M(+1.8%) |
| Sep 2024 | - | -$11.32 M(-23.1%) | -$61.20 M(-10.4%) |
| Jun 2024 | - | -$14.73 M(-30.5%) | -$68.28 M(+0.5%) |
| Mar 2024 | - | -$21.20 M(+51.9%) | -$67.92 M(+1.7%) |
| Dec 2023 | -$66.75 M(-21.7%) | -$13.96 M(-24.1%) | -$66.75 M(-10.7%) |
| Sep 2023 | - | -$18.39 M(+28.0%) | -$74.73 M(+2.6%) |
| Jun 2023 | - | -$14.37 M(-28.3%) | -$72.81 M(-5.1%) |
| Mar 2023 | - | -$20.03 M(-8.7%) | -$76.70 M(-10.1%) |
| Dec 2022 | -$85.27 M(-17.1%) | -$21.94 M(+33.2%) | -$85.27 M(-2.8%) |
| Sep 2022 | - | -$16.47 M(-9.8%) | -$87.71 M(-11.6%) |
| Jun 2022 | - | -$18.26 M(-36.2%) | -$99.22 M(-7.2%) |
| Mar 2022 | - | -$28.61 M(+17.3%) | -$106.97 M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$102.86 M(+96.7%) | -$24.38 M(-12.8%) | -$102.86 M(+9.0%) |
| Sep 2021 | - | -$27.97 M(+7.5%) | -$94.36 M(+21.2%) |
| Jun 2021 | - | -$26.01 M(+6.2%) | -$77.89 M(+19.0%) |
| Mar 2021 | - | -$24.50 M(+54.2%) | -$65.46 M(+25.2%) |
| Dec 2020 | -$52.29 M(+111.7%) | -$15.88 M(+38.2%) | -$52.29 M(+19.1%) |
| Sep 2020 | - | -$11.49 M(-15.4%) | -$43.89 M(+16.4%) |
| Jun 2020 | - | -$13.59 M(+20.1%) | -$37.72 M(+29.5%) |
| Mar 2020 | - | -$11.32 M(+51.2%) | -$29.13 M(+17.9%) |
| Dec 2019 | -$24.70 M(+189.5%) | -$7.49 M(+40.7%) | -$24.70 M(+43.5%) |
| Sep 2019 | - | -$5.32 M(+6.5%) | -$17.21 M(+44.8%) |
| Jun 2019 | - | -$5.00 M(-27.4%) | -$11.89 M(+72.6%) |
| Mar 2019 | - | -$6.89 M | -$6.89 M |
| Dec 2018 | -$8.53 M(+251.3%) | - | - |
| Dec 2017 | -$2.43 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual free cash flow?
- What is the all time high annual FCF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual FCF year-on-year change?
- What is Black Diamond Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly FCF year-on-year change?
- What is Black Diamond Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM FCF year-on-year change?
What is Black Diamond Therapeutics annual free cash flow?
The current annual FCF of BDTX is -$62.30 M
What is the all time high annual FCF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual free cash flow is -$2.43 M
What is Black Diamond Therapeutics annual FCF year-on-year change?
Over the past year, BDTX annual free cash flow has changed by +$4.45 M (+6.66%)
What is Black Diamond Therapeutics quarterly free cash flow?
The current quarterly FCF of BDTX is -$15.05 M
What is the all time high quarterly FCF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly free cash flow is -$5.00 M
What is Black Diamond Therapeutics quarterly FCF year-on-year change?
Over the past year, BDTX quarterly free cash flow has changed by -$1.10 M (-7.87%)
What is Black Diamond Therapeutics TTM free cash flow?
The current TTM FCF of BDTX is -$62.30 M
What is the all time high TTM FCF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM free cash flow is -$6.89 M
What is Black Diamond Therapeutics TTM FCF year-on-year change?
Over the past year, BDTX TTM free cash flow has changed by +$4.45 M (+6.66%)